Global Gastrointestinal Anastomosis Market to grow at a CAGR of 6.13% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The demand for gastrointestinal anastomosis devices is steadily increasing, largely due to the growing prevalence of gastrointestinal disorders, including inflammatory bowel disease (IBD), ulcerative colitis, Crohn's disease, and various gastrointestinal cancers. These conditions frequently require surgical interventions such as bowel resections, which rely on anastomosis devices to reconnect sections of the digestive tract. Furthermore, the rising volume of gastrointestinal surgeries performed worldwide is driving the need for effective and reliable anastomosis solutions. These devices are essential for ensuring secure reconnections and reducing the risk of postoperative complications.

DelveInsight's "Gastrointestinal Anastomosis Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Gastrointestinal Anastomosis companies actively working in the market.

To know more about why North America is leading the market growth in the Gastrointestinal Anastomosis market, get a snapshot of the report Gastrointestinal Anastomosis Market Trends
https://www.delveinsight.com/sample-request/gastrointestinal-anastomosis-market?utm_source=openpr&utm_medium=promotion&utm_campaign=gpr

Gastrointestinal Anastomosis Overview
Gastrointestinal Anastomosis is a surgical procedure that connects two segments of the gastrointestinal (GI) tract, such as the stomach, small intestine, or colon, after a portion has been removed or bypassed. This technique restores the continuity of the digestive system, allowing normal passage of food and fluids. It is commonly performed during surgeries for cancer, inflammatory bowel disease, ulcers, or bowel obstructions. Gastrointestinal anastomosis can be done using stapling devices or sutures, and advancements in minimally invasive and robotic-assisted techniques have improved precision, reduced complications, and enhanced patient recovery.

DelveInsight Analysis: The gastrointestinal anastomosis market size is projected to expand at a CAGR of 6.13% between 2025 and 2032.

Gastrointestinal Anastomosis Market Insights
Geographically, North America is expected to maintain the largest share of the gastrointestinal anastomosis market in 2024, supported by several key factors. The region's leadership is mainly due to the increasing prevalence of gastrointestinal disorders, including inflammatory bowel disease and gastric cancer, along with a well-developed healthcare infrastructure and multiple product approvals and launches by major industry players. Together, these elements establish North America as the dominant market in the global gastrointestinal anastomosis sector.

To read more about the latest highlights related to Gastrointestinal Anastomosis, get a snapshot of the key highlights entailed in the Gastrointestinal Anastomosis Insights
https://www.delveinsight.com/report-store/gastrointestinal-anastomosis-market?utm_source=openpr&utm_medium=promotion&utm_campaign=gpr

Recent Developments in the Gastrointestinal Anastomosis Market Report
• In March 2025, GT MetabolicTM Solutions, Inc. announced that the U.S. FDA had cleared a larger 50mm MagDITM System magnet, complementing the existing 40mm version. This expansion allows surgeons to treat a wider range of patients using magnet-assisted surgery for duodenal-ileal anastomosis, enhancing procedural flexibility and clinical outcomes.
• In August 2024, Colospan announced that the U.S. FDA granted Breakthrough Device Designation to its CG-100 Intraluminal Bypass Device. This single-use, temporary device is designed for patients with colorectal cancer requiring an anastomosis and typically receiving a protective stoma, offering a less invasive alternative under standard clinical practice.
• In May 2024, Exero Medical launched an international pivotal study to monitor post-gastrointestinal surgery recovery. The study is designed to provide real-time, accurate data on patients' healing progress, helping personalize care and quickly detect potential life-threatening complications.
• Thus, owing to such developments in the market, rapid growth will be observed in the Gastrointestinal Anastomosis market during the forecast period

Key Players in the Gastrointestinal Anastomosis Market
Some of the key market players operating in the Gastrointestinal Anastomosis market include- Medtronic, NiTiTM Surgical Solutions, Inc., Johnson & Johnson Services, Inc., Smith+Nephew, B. Braun Melsungen AG, Peters Surgical, LeMaitre Vascular, Inc., Baxter, Advanced Medical Solutions Group plc., Microbot Medical, Intuitive Surgical, GT Metabolic Solutions, Inc., Boston Scientific Corporation, Ovesco Endoscopy AG, Seger Surgical Solutions Ltd., Cook, EziSurg Medical Co., Ltd., Lotus Surgicals, Artivion, Inc., Teleflex Incorporated, and others.

Which MedTech key players in the Gastrointestinal Anastomosis market are set to emerge as the trendsetter explore @ Key Gastrointestinal Anastomosis Companies
https://www.delveinsight.com/sample-request/gastrointestinal-anastomosis-market?utm_source=openpr&utm_medium=promotion&utm_campaign=gpr

Analysis on the Gastrointestinal Anastomosis Market Landscape
Modern stapling devices, such as tissue-sensing systems and tri-staple configurations, automatically adjust staple height and compression according to tissue thickness, enhancing healing outcomes. For instance, Johnson & Johnson MedTech's ECHELON CIRCULARTM Powered Stapler is engineered to provide secure anastomoses in end-to-end, end-to-side, and side-to-side configurations across the alimentary tract.
Additionally, key market players are continually innovating and expanding their product offerings to address evolving surgical needs. In April 2025, Intuitive Surgical obtained FDA clearance for its fully wristed SP SureForm 45 Stapler, compatible with the da Vinci SP robotic system for gastric and colorectal surgeries.
These advancements are expected to drive growth in the gastrointestinal anastomosis devices segment, contributing to the overall expansion of the global market.

Scope of the Gastrointestinal Anastomosis Market Report
• Coverage: Global
• Study Period: 2022-2032
• Gastrointestinal Anastomosis Market Segmentation By Product Type: Instruments [Stapler, Clips, Rings, and Sutures] and Consumables
• Gastrointestinal Anastomosis Market Segmentation By Anastomose Type: End-to-End, Side-to-Side, and End-to-Side
• Gastrointestinal Anastomosis Market Segmentation By Usability: Re-usable and Single-use
• Gastrointestinal Anastomosis Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
• Gastrointestinal Anastomosis Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Gastrointestinal Anastomosis Companies: Medtronic, NiTiTM Surgical Solutions, Inc., Johnson & Johnson Services, Inc., Smith+Nephew, B. Braun Melsungen AG, Peters Surgical, LeMaitre Vascular, Inc., Baxter, Advanced Medical Solutions Group plc., Microbot Medical, Intuitive Surgical, GT Metabolic Solutions, Inc., Boston Scientific Corporation, Ovesco Endoscopy AG, Seger Surgical Solutions Ltd., Cook, EziSurg Medical Co., Ltd., Lotus Surgicals, Artivion, Inc., Teleflex Incorporated, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Gastrointestinal Anastomosis market will grow by 2032? Click to get a snapshot of the Gastrointestinal Anastomosis Market Analysis
https://www.delveinsight.com/sample-request/gastrointestinal-anastomosis-market?utm_source=openpr&utm_medium=promotion&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.